Accordingly, nitro fatty acids directly modify STING1 palmitoylation by nitro alkylation, leading to the inhibition of type I IFN production in fibroblasts derived from SAVI patients (54). This evidence concerns the gene STING1 and STING-associated vasculopathy with onset in infancy.